Please use this identifier to cite or link to this item:
https://doi.org/10.3390/molecules17044703
| Title: | Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6- phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives | Authors: | Ding, H. Chen, Z. Zhang, C. Xin, T. Wang, Y. Song, H. Jiang, Y. Chen, Y. Xu, Y. Tan, C. |
Keywords: | 1-b]thiazoles Cytotoxic activity Imidazo[2 Synthesis |
Issue Date: | Apr-2012 | Citation: | Ding, H., Chen, Z., Zhang, C., Xin, T., Wang, Y., Song, H., Jiang, Y., Chen, Y., Xu, Y., Tan, C. (2012-04). Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6- phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives. Molecules 17 (4) : 4703-4716. ScholarBank@NUS Repository. https://doi.org/10.3390/molecules17044703 | Abstract: | A series of novel compounds bearing imidazo[2,1-b]thiazole scaffolds were designed and synthesized based on the optimization of the virtual screening hit compound N-(6-morpholinopyridin-3-yl)-2-(6-phenylimidazo[2,1-b]thiazol-3-yl) acetamide (5a), and tested for their cytotoxicity against human cancer cell lines, including HepG2 and MDA-MB-231. The results indicated that the compound 2-(6-(4-chlorophenyl)imidazo [2,1-b]thiazol-3-yl)-N-(6-(4-(4-methoxybenzyl) piperazin-1-yl)pyridin-3-yl)acetamide (5l), with slightly higher inhibition on VEGFR2 than 5a (5.72% and 3.76% inhibitory rate at 20 μM, respectively), was a potential inhibitor against MDA-MB-231 (IC50 = 1.4 μM) compared with sorafenib (IC50 = 5.2 μM), and showed more selectivity against MDA-MB-231 than HepG2 cell line (IC50 = 22.6 μM). © 2012 by the authors. | Source Title: | Molecules | URI: | http://scholarbank.nus.edu.sg/handle/10635/106392 | ISSN: | 14203049 | DOI: | 10.3390/molecules17044703 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.